Pathstone Holdings, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 2011612 ENGLEWOOD, NJ

Position in TEVA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,027,454

+$1,087,685 QoQ

Shares Held

177,906

+8.5% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#182

of 673 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 89% Shared 0% None 10%

Healthcare · as of Jun 30, 2026

Pathstone Holdings, LLC holds $42,015,720 across 17 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (14.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	273,446	$6,729,505
2	TEVA	Teva Pharmaceutical Industries Ltd This page	177,906	$6,027,454
3	ZTS	Zoetis Inc.	74,081	$5,323,460
4	ALKS	Alkermes plc.	82,327	$4,313,934
5	TAK	Takeda Pharmaceutical Co Ltd	239,306	$3,836,074
6	UTHR	UNITED THERAPEUTICS Corp	5,129	$2,779,045
7	HIMS	Hims & Hers Health, Inc.	70,526	$2,445,136
8	NBIX	Neurocrine Biosciences Inc	13,005	$2,191,862

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,027,454	177,906	+8.5%	Shares	Other	2026-08-13
2026-03-31	$4,939,769	164,003	+139.7%	Shares	Other	2026-05-11
2025-12-31	$2,134,950	68,406	+0.8%	Shares	Defined	2026-02-13
2025-09-30	$1,371,256	67,884	+1.2%	Shares	Other	2025-11-13
2025-06-30	$1,124,460	67,092	-4.6%	Shares	Sole	2025-08-12
2025-03-31	$1,080,448	70,296	-5.8%	Shares	Other	2025-05-15
2024-12-31	$1,645,351	74,653	+2.8%	Shares	Defined	2025-02-14
2024-09-30	$1,308,215	72,598	+6.5%	Shares	Sole	2024-11-07
2024-06-30	$1,107,372	68,146	+7.8%	Shares	Defined	2024-08-14
2024-03-31	$891,949	63,214	+43.9%	Shares	Sole	2024-05-13
2023-12-31	$458,617	43,929	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.